Pharmacologic perturbation of neutrophils by Fluosol results in a sustained reduction in infarct size in the canine model of reperfusion
- 31 January 1992
- journal article
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 19 (1), 205-216
- https://doi.org/10.1016/0735-1097(92)90074-w
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Limitation of myocardial reperfusion injury by intravenous perfluorochemicals. Role of neutrophil activation.Circulation, 1989
- Endothelial and myocardial injury during ischemia and reperfusion: Pathogenesis and therapeutic implicationsJournal of the American College of Cardiology, 1989
- Neutrophil accumulation in experimental myocardial infarcts: relation with extent of injury and effect of reperfusion.Circulation, 1987
- Myocardial reperfusion: a double-edged sword?Journal of Clinical Investigation, 1985
- Failure of the xanthine oxidase inhibitor allopurinol to limit infarct size after ischemia and reperfusion in dogs.Circulation, 1985
- Reduction of infarct size with intracoronary perfluorochemical in a canine preparation of reperfusion.Circulation, 1985
- Animal models for protecting ischemic myocardium: results of the NHLBI Cooperative Study. Comparison of unconscious and conscious dog models.Circulation Research, 1985
- Clinical Use of a Blood SubstituteNew England Journal of Medicine, 1980
- The loss of radioactive microspheres from canine necrotic myocardium.Circulation Research, 1979
- The speed of healing of myocardial infarctionAmerican Heart Journal, 1939